|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net (loss) income to net cash, cash equivalents, and restricted cash provided by operating activities: | |||||
| Depreciation and amortization of intangibles | |||||
| Amortization of debt discount and issuance costs | |||||
| Vacation ownership notes receivable reserve | |||||
| Share-based compensation | |||||
| Impairment | |||||
| Gains and other income, net | |||||
| Foreign currency remeasurement (gain) loss | |||||
| Deferred income taxes | |||||
| Net change in assets and liabilities: | |||||
| Accounts and contracts receivable | |||||
| Vacation ownership notes receivable originations | |||||
| Vacation ownership notes receivable collections | |||||
| Inventory | |||||
| Other assets | |||||
| Accounts payable, advance deposits and accrued liabilities | |||||
| Deferred revenue and other | |||||
| Payroll and benefit liabilities | |||||
| Deferred compensation liability | |||||
| Other liabilities | |||||
| Deconsolidation of certain Consolidated Property Owners' Associations | |||||
| Purchase and development of property for future transfer to inventory | |||||
| Other, net | |||||
| Net cash, cash equivalents, and restricted cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Acquisition of a business, net of cash and restricted cash acquired | |||||
| Proceeds from disposition of subsidiaries, net of cash and restricted cash transferred | |||||
| Capital expenditures for property and equipment (excluding inventory) | |||||
| Issuance of note receivable to VIE | |||||
| Proceeds from collection of note receivable from VIE | |||||
| Purchase of company owned life insurance | |||||
| Purchase and development of property for future sale | |||||
| Dispositions, net | |||||
| Other, net | |||||
| Net cash, cash equivalents, and restricted cash used in investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Borrowings from securitization transactions | |||||
| Repayment of debt related to securitization transactions | |||||
| Proceeds from debt | |||||
| Repayments of debt | |||||
| Purchase of convertible note hedges | |||||
| Proceeds from issuance of warrants | |||||
| Finance lease incentive | |||||
| Finance lease payment | |||||
| Payment of debt and securitized debt issuance costs | |||||
| Repurchase of common stock | |||||
| Payment of dividends | |||||
| Payment of withholding taxes on vesting of restricted stock units | |||||
| Net cash, cash equivalents, and restricted cash provided by (used in) financing activities | |||||
| Effect of changes in exchange rates on cash, cash equivalents, and restricted cash | |||||
| Change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of year | |||||
| Cash, cash equivalents, and restricted cash, end of year | |||||
| SUPPLEMENTAL DISCLOSURES | |||||
| Non-cash issuance of debt in connection with asset acquisition | |||||
| Non-cash issuance of treasury stock in connection with Welk Acquisition | |||||
| Non-cash transfer from inventory to property and equipment | |||||
| Non-cash transfer from property and equipment to inventory | |||||
| Non-cash transfer from property and equipment to other assets | |||||
| Non-cash transfer from other assets to property and equipment | |||||
| Non-cash issuance of treasury stock for employee stock purchase plan | |||||
| Dividends payable | |||||
| Interest paid, net of amounts capitalized | |||||
| Income taxes paid, net of refunds | |||||
Loading...